Kapila Ratnam serves as a Partner at NewSpring Capital. Where she focuses on the healthcare sector, covering technology-enabled services (including healthcare IT), pharmaceutical services and specialty pharmaceuticals (particularly, generics and post-approval products).

Her prior experience is in drug discovery and development, as well as enabling biotechnologies. Her therapeutic domain knowledge, which spans several disease areas, was gained at pharmaceutical companies and contract research organizations. Kapila’s Board roles include Paragon Bioservices Inc., Putney Inc., PDI, Inc. She has played active roles in several other current and former NewSpring portfolio companies.

She has a Ph.D. from the Ohio State University and completed her postdoctoral training at the University of Pennsylvania. Dr. Ratnam also has an MBA from Columbia University.

Education:
Ohio State University, Ph.d (Doctor of Philosophy), Biochemistry
Columbia Business School, MBA (Master of Business Administration), 2007